MMWR recomm. rep; 64 (11), 2015

GRADE was used to evaluate 9vHPV for routine vaccination of females and males aged 11 or 12 years as well as catch-up vaccination of females aged 13 through 26 years and males aged 13 through 21 years who were not vaccinated previously. Evidence of benefits, harms, values and preferences, and cost-effect...

Fulltext

This publication, Comprehensive cervical cancer control: a guide to essential practice (C4GEP), gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and c...

Fulltext (primary link)     Fulltext (alternative link)     Fulltext (alternative link)     Fulltext (alternative link)     Fulltext (alternative link)    

MMWR recomm. rep; 60 (50), 2011

Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods (Ahmed F, et al). The primary policy question was “Should HPV4 be recommended for routine use in 11-12 year old boys.” The benefits considered included prevention of genital wart...

Fulltext